Company profile: Sterling Pharma Solutions
1.1 - Company Overview
Company description
- Provider of small molecule API development and manufacturing services for the global pharmaceutical industry, from pre-clinical to commercial. Offers ADC pre-clinical bioconjugation services with potent cytotoxin handling; PDMO® collaborative API development and integrated project management; hazardous chemistry; high potency and controlled substance API manufacturing; and peptide API development with large-scale chromatography.
Products and services
- Small Molecule API Development and Manufacturing: Delivers commercial-scale small molecule API engineering and production, supporting global pharma from pre-clinical development through full commercial manufacturing of active pharmaceutical ingredients (APIs)
- High Potency API Manufacturing: Produces high-potency APIs, offering manufacturing services that include controlled-substance handling and production for highly active compounds used in demanding pharmaceutical applications
- Hazardous Chemistry: Supplies specialized services for API development and manufacturing that involve hazardous chemical processes for small molecule production
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sterling Pharma Solutions
Patheon
HQ: United States
Website
- Description: Provider of commercial manufacturing and pharmaceutical development services to pharmaceutical and biotechnology industries worldwide, spanning solid, semi-solid, liquid, and sterile dosage forms. Offers contract development and manufacturing from preclinical to commercialization, clinical trial strategy and operations, commercial services, advanced therapies (viral vectors, cell therapy, mRNA), biologics, and small molecule development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Patheon company profile →
JSS Medical Research
HQ: Canada
Website
- Description: Provider of full-service clinical research organization (CRO) with strong academic affiliations, offering services internationally, including management of Phase I-III clinical trials; design and execution of late and post-approval studies; market access and HEOR (budget impact analysis, cost-effectiveness models); regulatory and clinical development consulting; biostatistics; and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JSS Medical Research company profile →
BioVectra
HQ: Canada
Website
- Description: Provider of contract development and manufacturing services for intermediates and active pharmaceutical ingredients, with over 40 years' experience serving global pharmaceutical and biotechnology clients. Capabilities span synthetic organic chemistry, microbial fermentation for biologics (e.g., recombinant insulin), synthetic small molecules, highly potent APIs, bioreagents, and pDNA/mRNA production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioVectra company profile →
Aquila BioMedical
HQ: United Kingdom
Website
- Description: Provider of pre-clinical contract research services with expertise in immuno-oncology, immunology, and multiplex histology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aquila BioMedical company profile →
NJ Bio
HQ: United States
Website
- Description: Provider of integrated chemistry and biology CRO/CDMO services for biotech and pharma, including bioconjugation and antibody-drug conjugates, protein production, and cell-based assays. Offerings include express, standard, and custom conjugations for ADC assessment and validation, protein/peptide drug conjugates, and carrier protein conjugates for vaccines and antibody generation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NJ Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sterling Pharma Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sterling Pharma Solutions
2.2 - Growth funds investing in similar companies to Sterling Pharma Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sterling Pharma Solutions
4.2 - Public trading comparable groups for Sterling Pharma Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →